A carregar...
FGFR3 Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer
FGFR3 is a prognostic and predictive marker and is a validated therapeutic target in urothelial bladder cancer. Its utility as a marker and target in the context of immunotherapy is incompletely understood. We review the role of FGFR3 in bladder cancer and discuss preclinical and clinical clues of i...
Na minha lista:
| Publicado no: | Front Immunol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7674585/ https://ncbi.nlm.nih.gov/pubmed/33224141 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.575258 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|